Print

Innogenetics (INGTF.PK) Grants Cervical Cancer Licence to GlaxoSmithKline (GSK)  
7/2/2008 7:20:29 AM

BRUSSELS, July 1 (Reuters) - Belgian biotech company Innogenetics said on Tuesday it had granted GlaxoSmithKline a worldwide, non-exclusive license to use its technology in cervical cancer vaccine studies.
//-->